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Abstract
Background: Dengue fever regardless of its serotypes has been the most prevalent arthropod-borne viral diseases
among the world population. The development of a dengue vaccine is complicated by the antibody-dependent
enhancement effect. Thus, the development of a plant-based antiviral preparation promises a more potential
alternative in combating dengue disease.
Methods: Present studies investigated the antiviral effects of standardised methanolic extracts of Andrographis
paniculata, Citrus limon, Cymbopogon citratus, Momordica charantia, Ocimum sanctum and Pelargonium citrosum on
dengue virus serotype 1 (DENV-1).
Results: O. sanctum contained 88.6% of total flavonoids content, an amount that was the highest among all the
six plants tested while the least was detected in M. charantia. In this study, the maximum non-toxic dose (MNTD)
of the six medicinal plants was determined by testing the methanolic extracts against Vero E6 cells in vitro. Studies
also determined that the MNTD of methanolic extract was in the decreasing order of M. charantia >C. limon >P.
citrosum, O. sanctum >A. paniculata >C. citratus. Antiviral assay based on cytopathic effects (CPE) denoted by
degree of inhibition upon treating DENV1-infected Vero E6 cells with MNTD of six medicinal plants showed that A.
paniculata has the most antiviral inhibitory effects followed by M. charantia. These results were further verified with
an in vitro inhibition assay using MTT, in which 113.0% and 98.0% of cell viability were recorded as opposed to
44.6% in DENV-1 infected cells. Although methanolic extracts of O. sanctum and C. citratus showed slight inhibition
effect based on CPE, a significant inhibition was not reflected in MTT assay. Methanolic extracts of C. limon and P.
citrosum did not prevent cytopathic effects or cell death from DENV-1.
Conclusions: The methanol extracts of A. paniculata and M. charantia possess the ability of inhibiting the activity
of DENV-1 in in vitro assays. Both of these plants are worth to be further investigated and might be advantageous
as an alternative for dengue treatment.
Background
Dengue disease regardless of its serotypes is transmitted
from person to person by Aedes aegypti and Aedes albo-
pictus mosquitoes in the domestic environment [1]. In
the recent decade, dengue has re-emerged and with it
being endemic in more than 110 countries, it has been
the most prevalent arthropod-borne viral diseases in
terms of morbidity and mortality [2]. Two fifths of the
world populations are at risk, estimating around 100
million of dengue fever infections, 2.1 million cases of
dengue hemorrhagic fever and 200 thousand deaths
worldwide are caused by dengue every year. Despite
extremely high rates of dengue for decades, Southeast
Asia region still recorded an increase of 67% from 1985-
1989 to 2002-2006 [3]. Similarly, a total of 4.6-fold
increase in dengue cases has also been reported in
America over the three decades [3].
Dengue appears in two forms; the first classic dengue
fever with symptoms that range from mild fever to high
fever with retro-orbital pain, severe headaches, maculo-
papular rashes, muscle and joint pain. The other more
severe form, Dengue Hemorrhagic Fever (DHF) and
Dengue Shock Syndrome (DSS) may present with
abdominal bleeding, hemorrhage and circulatory failure,
which is fatal if without prompt and proper
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management [4]. There are four serologic types of den-
gue virus, DENV-1, -2, -3 and -4. A primary infection
with any of the four serotypes results in a lifelong
immunity to that serotype, and temporary immunity to
the others. However, this temporary immunity usually
wanes after 6 months, at which point an individual is
susceptible to the other three DENV serotypes [5]. The
primary infection is most often asymptomatic, but
sequential infections in the presence of heterologous
dengue antibodies often leads to a more severe second-
ary infection causing DHF or DSS. Murrel et al. [5]
attributed this to the antibody-dependent enhancement
(ADE) effect. Studies on the outbreaks in endemic areas,
such as South East Asia revealed that a primary infec-
tion with DENV-1 or DENV-3 frequently resulted in a
more severe disease than if DENV-2 or DEV-4 were the
primary infection [6].
With the rapid expansion of dengue disease in most
tropical and subtropical areas of the world, it is crucial
to develop effective prevention and control measures,
including antiviral drugs and vaccines against dengue
disease. However, the development of a dengue vaccine
is complicated by the ADE effect, which happens when
a child experiences a second dengue infection with a dif-
ferent serotype from the previous infection, causing
DHF/DSS. The vaccine must not only protect against all
four dengue serotypes but also must avoid inducing the
ADE effect. Early studies have shown that extract from
different parts of plants could provide good antiviral
results as compared to their synthetic analogues [7]. As
such, the development of a plant-based antiviral pre-
paration promises a more potential alternative in com-
bating dengue disease. Over the years, the World Health
Organization (WHO) advocated that countries should
interact with traditional medicine with a view to identify
and exploit aspects that provide safe and effective reme-
dies for ailments of antiviral. In addition, there are still
no antiviral drugs being tested against dengue disease in
any clinical trials. As such, present studies aimed to
screen and determine the anti-dengue activity of metha-
nolic extracts of Andrographis paniculata (Burm. f.)
Nees, Citrus limon (L.) Burm. f., Cymbopogon citratus
(DC.) Stapf, Momordica charantia L, Ocimum sanctum
L. and Pelargonium citrosum, which have been used as
folk medicine for dengue.
Methods
Plant materials and extraction
Andrographis paniculata, Ocimum sanctum, Pelargo-
nium citrosum and Cymbopogon citratus plants were col-
lected from Sungai Buluh, Selangor, Malaysia while
Citrus limon and Momordica charantia were collected
from Sibu, Sarawak and Sri Serdang, Selangor, respec-
tively. The botanical identities of each plant were
determined and authenticated by taxonomist from Insti-
tute of Bioscience, University Putra Malaysia. After the
taxonomy identification, the plants were washed and
cleaned prior to air drying at room temperature for one
week. The whole aerial body of A. paniculata, O. sanc-
tum, P. citrosum and C. citratus was blended and used.
As for C. limon and M. charantia, the roots and entire
fruits were utilised, respectively. Upon drying, 100 g of
the plant materials were ground to powder and extracted
consecutively with 500 mL of absolute methanol (Fisher
Scientific, UK) for three to four days in dark condition.
The resulting suspension was filtered and evaporated
under reduced pressure at 50°C until dryness.
Standardisation of extracts
Standardisation of extracts was carried out based on the
total flavanoids content of the extracts measured using
aluminium chloride colourimetric assay as described by
Pourmorad et al. [8]. For this assay, 0.1 mg of extract was
dissolved in 1 mL of methanol. The solution was then
mixed with 0.1 mLof 10% (v/v) aluminium chloride
(Sigma-Aldrich, USA), 0.1 mL of 1 M potassium acetate
(Sigma-Aldrich, USA) and 2.8 mL of distilled water. After
30 minutes of incubation at room temperature, the absor-
bance reading of the reaction mixture was measured at
415 nm using spectrophotometer (UV-Vis Spectrophot-
ometer, Japan) with methanol as blank. A standard curve
was constructed using quercetin (Sigma-Aldrich, USA) as
the standard at the concentrations ranging from 50 to 200
μg/mL. Total flavonoids content of the extracts was then
compared with the standard curve, expressed in mg quer-
cetin equivalents per 100 g dry weight (mg QE/100 g DW)
and further calculated as % of total flavonoids content.
Preparation of extracts
For the cytotoxicity and antiviral assays, a stock solution
was prepared by dissolving 2.0 g of extract in 100 mL of
dimethyl sulfoxide (DMSO) (Sigma Aldrich, USA). The
stock solution was filter sterilised (0.20 μm pore, Minis-
art) and further diluted with culture medium to the
desired concentration for the assays.
Preparation of medium
Powdered Dulbecco’s Modified Eagle’s Medium
(DMEM) (GIBCO, UK) was used in this study. A total
of 3.7 g of sodium bicarbonate was added, dissolved
with 1 L of ultrapure water and the pH of the medium
was adjusted to 7.0. The medium was then filter steri-
lised using 0.22 μm PES membrane filter (TPP, Switzer-
land) under vacuum condition.
Maintenance of Vero E6 cells
The cryopreserved Vero E6 cells were rapidly thawed at
37°C in a water bath. Cells were transferred carefully to
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25 cm2 tissue culture flasks (Corning, USA) containing 4
mL of DMEM with 10% of Fetal Bovine Serum (FBS)
(GIBCO, South America). Cells were then incubated at
37°C with 5% CO2 for 2 to 3 days until confluent.
At 80-100% confluency, the cells were subcultured.
The subculturing process was initiated by removing the
used medium followed by rinsing the cells twice with
Phosphate buffer solution (PBS) (MP Biomedical,
France). Then, 1 mL of 0.25% trypsin-EDTA (GIBCO,
Canada) was added and incubated for 5 to 10 minutes
at 37°C. After trypsinisation, 1 mL of fresh medium
with 10% FBS was added and mixed. The mixture was
then centrifuged for 10 minutes at 1500 rpm. The
supernatant was discarded while the pellet was resus-
pended with 2 mL of fresh medium and re-distributed
into new tissue culture flask for further maintenance.
Preparation of virus stock
The serotype of dengue virus obtained from Makmal
Kesihatan Awam Kebangsaan (MKAM), Malaysia was
confirmed through Polymerase Chain Reaction (PCR)
and sequencing. The PCR was conducted based on the
protocols described by Liu et al. [9]. In brief, the nucleo-
tide sequence (~400 bp) of the dengue virus was ampli-
fied using the primers, AD3 5’ CTGATTTCCATC
CCGTA 3’ and AD4 5’ CATATGGGTTATTGGA
TAGA 3’. The PCR products were then sequenced. The
sequencing results were compared with the library
sequences using Basic Local Alignment Search Tool
(BLAST). Thus, the dengue virus obtained was con-
firmed to be of serotype 1 (DENV-1).
The stock of dengue virus was obtained by adding 1
mL of DENV-1 to confluent Vero E6 cells and gently
shaken for 1 hour to maximise the viral adsorption to
the cells. After which, 4 mL of fresh medium with 10%
FBS was added prior to incubation at 37°C with 5% CO2
for six to seven days. Supernatant was then collected
and stored at -80°C. These were repeated for several
times until adequate virus stock was collected.
Determination of maximum non-toxic dose (MNTD)
The in vitro cytotoxicity assay was carried out on the
extracts to determine the MNTD on Vero E6 cells. The
cytotoxicity assay was initiated by seeding 1.5 × 104 cells
into 96 well flat-bottom plates (Corning, USA). A blank
control (medium only) and cell control (cells only) were
also plated. The plate was then incubated in 5% CO2
humidified incubator (RS biotech, Galaxy S) for 24
hours. After 24 hours, the cells were treated with diluted
stock extract at the concentrations ranging from 0.05 to
2.5 mg/mL, and later further incubated at 37°C with 5%
CO2.
After 96 hours, 20 μL of 3-(4,5-Dimethylthiazol-2-yl)-
2,5-diphenyltetrazolium bromide (MTT) salt solution
was added into each well and incubated for 4 hours.
After 4 hours, the supernatant of the well was carefully
removed. A total of 100 μL of DMSO was added fol-
lowed by continuous shaking for 10 minutes. The absor-
bance reading of each well was measured using
microplate reader (Tecan, Austria) at 570 nm. The per-
centage of cell viability and toxicity was further deter-
mined based on the absorbance readings.
Determination of median tissue culture infective dose
(TCID50)
A total of 1.5 × 104 cells/well were seeded into 96-well
plate and incubated at 37°C with 5% CO2. After 24
hours, a total volume of 100 μL of ten-fold serially
diluted DENV-1 was inoculated into each well with 10
replicates for each dilution. Plates were further incu-
bated at 37°C for 5 days, after which cytopathic effect
(CPE) was observed microscopically under inverted
microscope. To determine the TCID50 based on Karber
method [10], the presence of CPE in each well was
marked as ‘+’, while its absence was marked as ‘-’. The
proportion of wells with CPE in each serially diluted
DENV-1 was calculated and the TCID50 was estimated
using the formula ‘Log TCID50 = L - d (s - 0.5)’,
whereby L = lowest dilution factor; d = difference
between dilution steps; s = sum of proportion. The
value of TCID50 determined was applied in the antiviral
assay.
In vitro antiviral assay
The in vitro antiviral assay was initiated by seeding 1.5 ×
104 cells/well into each well of 96-well plate, and left to
incubate at 37°C with 5% CO2 for 24 hours. After 24
hours, the medium was removed and 100 μL of each
plant extract at its MNTD was added. After incubating
for 1 hour, 100 μL of DENV-1 at its TCID50 was added.
The assay was also conducted with the controls, which
included the cells alone, cells treated with extracts and
cells with DENV-1. The 96-well plate was further incu-
bated for five days, after which the CPE of the cells
were observed under inverted microscope on a daily
basis. The antiviral effect of each plant extract was
assessed using a grading system as described by Kudi
and Myint [11], whereby the degree of CPE inhibition
upon treatment was marked at the following order: ‘+++
+’ represented a total inhibition, ‘+++’ for 75% inhibi-
tion, ‘++’ for 50% inhibition, ‘+’ for less than 50% inhibi-
tion, ‘-’ as no inhibition. The antiviral assay for each
plant extract was conducted in five replicates and
repeated twice.
The potency of these extracts on DENV-1 inhibition
were also further examined using MTT assay, in which
the percentage of viability of cells alone, cells infected
with DENV-1, and infected cells treated with extracts at
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MNTD were measured and compared. Statistical differ-
ence between treatments and positive control was ana-
lysed using unpaired t-test at p value less than 0.05 (p <




In this study, the methanol extracts of the six plants
were standardised based on the total flavonoids content
determined through aluminium chloride colourimetric
assay.
Earlier observations confirmed that flavonoids in
plants and their derivatives possess antiviral activity
[12,13]. Thus, in this study, the methanolic extracts
were standardised based on total flavonoids content
prior to antiviral assay. Present study reported that total
flavonoids content enfolded a total of 87% of the metha-
nolic extract of O. sanctum (Table 1). Medicinally
importance flavonoids identified in O. sanctum were
orientin, vicenin and luteolin [14,15]. Orientin and vice-
nin are reported to have radical scavenging activity [16]
while lutoelin is known to be anti-inflammatory agent
and have therapeutic action against multiple sclerosis
[17,18]. M. charantia possessed a total flavonoid content
of 21.7%, of which some of them could be luteolin, kam-
pherol and quercetin [19]. A study by Lin & Tang[20]
obtained a total flavonoids content that was slightly
lower, at a value of 15.0%. This could be due to the age
and geographical locations of the plants as well as the
temperature used during extraction [21]. In this study,
A. paniculata is another plant that recorded low amount
of total flavonoids content. In A. paniculata, some flavo-
noids that have been isolated were 7-O-methylwogonin,
apigenin, onysilin and 3,4-dicaffeoylquinic acid, which
are anti-atherosclerotic [22].
Meanwhile, C. limon possessed an average amount of
total flavonoids content (33%) among the six plants stu-
died. C. limon is a good source of flavonoids such as
hesperidin, diosmin and eriocitrin [23]. Root bark from
the Citrus spp. possessed the flavonoids; citrunobin, cit-
flavanone and lonchocarpol-A [24]. Meanwhile, C.
citratus showed an average total flavonoids content of
34.2%. Reported flavonoids isolated from C. citratus
were luteolin, apigenin, homoorintine flavanoides and its
2-O rhamnosil-limborientino [25,26]. Among the six
plants studied, P. citrosum recorded a high percentage
of total flavonoids content. The reason underlying high
flavonoids content in methanolic extracts of P. citrosum
is yet to be known as there is still a lack of investigation
on the flavonoid compounds in this plant. Up to now,
apart from the report on the presence of small amount
of tannins and coumarins [27], most of the studies on P.
citrosum have been focused on its main constituent,
essential oils.
Determination of maximum non-toxic dose (MNTD)
Prior to evaluating the anti-dengue properties of six
medicinal plants, their methanolic extracts were sub-
jected to toxicity studies in order to determine the max-
imal dose, which could be non-toxic to the cells. In this
study, the MNTD of the six medicinal plants was deter-
mined by testing the methanolic extracts against Vero
E6 cells in vitro. The studies were initiated by using ten-
fold serially diluted methanolic extracts of each plant
followed by further optimisation in order to achieve a
specific cytotoxic concentration. The MNTD of each
plant obtained through the optimization steps were pre-
sented in Figure 1.
In general, the cytotoxicity studies discovered that
MNTD for methanolic extract of M. charantia was 0.20
mg/mL, a value which was the highest among all the six
plants examined (Figure 1A). In contrast, MNTD of C.
citratus was the lowest, that was at a minute concentra-
tion of 0.001 mg/mL (Figure 1B) whilst the plant from
Acanthaceae family, A. paniculata recorded the second
lowest MNTD (0.050 mg/mL) (Figure 1C). Studies also
revealed that there was no significant difference in
MNTD values for C. limon, P. citrosum and O. sanctum
(Figures 1D-F), in which all the three extracts attained
MNTD that was two times higher as compared to A.
paniculata. In terms of the pattern of cytotoxity, the
extracts of C. citratus, A. paniculata, C. limon and M.
charantia showed steep rises of cytotoxicity and reached
the toxic limits over a narrow concentration range.
Among all the plants, C. citratus showed maximum
cytotoxicity at 0.075 mg/mL, indicating that it is the
most cytotoxic plant. Meanwhile, P. citrosum and O.
sanctum exhibited slow rises in cytotoxicity over a wide
range of concentrations.
Cytotoxic studies are essential for estimating the ther-
apeutic range of plant extract on mammalian cells. In
the present studies, both O. sanctum and P. citrosum
have the highest cytotoxic values (1.5 mg/mL and 2.5
mg/mL, respectively). A high cytotoxic value indicated
that these two plants were less toxic as compared to the
Table 1 The total flavonoids content of six medicinal
plants as determined through aluminium chloride
colourimetric assay.
Plant Total flavonoids content (%)
Momordica charantia 21.7 ± 10.9
Andrographis paniculata 24.3 ± 3.0
Citrus limon 32.6 ± 6.7
Cymbopogon citrates 35.2 ± 10.1
Pelargonium citrosum 61.1 ± 10.2
Ocimum sanctum 88.6 ± 21.4
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other four plants studied. As determined in this study,
these two plants also recorded the highest amount of
total flavonoids content. Hence, it is anticipated that the
flavonoids present in the methanolic extract might have
contributed to a high cytotoxic concentration. Flava-
noids have been reported to possess antioxidative activ-
ities, such as to inhibit lipid peroxidation, chelate redox-
active metals and inhibit free-radical mediated events
and even increasing resistance to DNA strand breakage
[28,29]. These protect the cells by scavenging of free
radicals that cause oxidative stress and can also induce
changes in membrane to reduce membrane lipid and
protein oxidation. Oteiza et al. [30] suggested that the
flavonoids interact at the surface of bilayers to reduce
the access of harmful oxidants, thus protecting the
structure and function of membranes.
In vitro antiviral assay
In order to screen the anti-dengue properties of metha-
nolic extracts of the six medicinal plants, in vitro
Figure 1 The percentage of toxicity of methanolic extracts of six plants on Vero E6 cells after incubated in vitro for 96 hours. (A)
Momordica charantia (B) Cymbopogon citratus (C) Andrographis paniculata (D) Citrus limon (E) Pelargonium citrosum (F) Ocimum sanctum. The
data shown are means ± S.D. of two independent experiments performed in triplicates.
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antiviral assay was conducted. The antiviral assay was
initiated using the MNTD of each plant extract against
TCID50. Prior to the qualitative observation of antiviral
assay, a grading system was developed according to
Kudi and Myint [11]. This system denoted the degree of
inhibition seen under inverted microscope using the ‘+’
symbol. The more ‘+’ symbols signified a higher percen-
tage of inhibition was observed whereas the ‘-’symbol
indicated no inhibition or widespread cell death. Thus,
‘++++’ represented a total inhibition, ‘+++’ for 75% inhi-
bition, ‘++’ for 50% inhibition, ‘+’ for less than 50% inhi-
bition and ‘-’ as no inhibition was observed upon the
treatment with methanolic extracts.
The Vero E6 cells grown in the tissue culture flasks
with DMEM supplemented with 10% FBS would form a
monolayer sheet of cells. The morphology of Vero E6
cells were clearly visualised using an inverted light
microscope. Under 200× magnification, the uninfected
Vero E6 cells were polygonal in shape with well defined,
black nuclei in the centre. The cytoplasm was shaded
grey but the cell membranes were clearly demarcated
with white lines surrounding the cells as shown in Fig-
ure 2.
Apart from the uninfected cells, the DENV1-infected
Vero E6 cells were also observed under inverted micro-
scope. The various cytopathic effects (CPE) after 7 days
post infection were examined at 100×, 200× and 400×
magnifications as some CPE could be better viewed at
different magnifications. From the observation, it was
clearly shown that DENV1-infected cells showed CPE,
which refers to the structural changes of the host cell
due to viral infection. Generally, in comparison to the
uninfected monolayer sheet of Vero E6 cells, DENV1-
infected cells appeared to have a congested and hapha-
zard pattern (Figure 3A). Cytopathic effects included
syncytia formation (Figure 3B) and cell lysis (Figure 3C).
Syncytia formation could be due to viral fusion proteins
being transported to the cell surface membranes, which
later fused with neighbouring cells. In addition, blebbing
of cells (Figure 3D), which referred to small detached
remnants of apoptotic bodies that have undergone pro-
grammed cell death could also be observed upon
DENV-1 infection.
Table 2 depicts the degree of inhibition on DENV-1
by the six medicinal plants. Among the six plants stu-
died, A. paniculata showed the most antiviral inhibitory
effects, that was 75% of inhibition. The methanolic
extract of A. paniculata was able to maintain most of
the normal cell morphologies without causing much
CPE to the DENV-1 infected cells. The monolayer sheet
of cells still remained normal with low amount of cells
death or lysis as well as low percentage of CPE (Figure
4A). In addition to A. paniculata, M. charantia also
exhibited moderate antiviral effects. Viable normal cells
were observable in the background. Nevertheless,
around 50% of the cells within the treatment showed
CPE, which was indicated by the changes of shape of
cells to spindle shaped (Figure 4B). The potency of
Figure 2 A monolayer sheet of uninfected Vero E6 cells. The normal cells were polygonal with well defined, black nuclei in the centre. The
cytoplasm was shaded grey with the cell membranes were clearly demarcated with white lines surrounding the cells. The cells were viewed
under inverted microscope at 200× magnification.
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these two extracts in inhibiting replication of DENV-1
was further confirmed through MTT assay, whereby the
viability of cells treated with both A. paniculata and M.
charantia extracts were not significantly affected upon
infection with DENV-1 (Table 3).
Current preliminary screening study based on CPE
also revealed that methanolic extracts of O. sanctum
and C. citratus showed a low inhibition (less than 50%)
against DENV-1. Observation of CPE under the inverted
microscope showed the presence of fragmented cells
and debris (Figures 4C and 4D). Nevertheless, this was
not in accordance with the MTT assay conducted as
only 48.0% and 32.0% of the cells treated with O. sanc-
tum and C. citrates survived upon DENV-1 infection,
respectively. The values recorded were not much dif-
fered from 44.6% achieved in the positive control that
infected with DENV-1 (Table 3). The variation in find-
ings based on CPE and MTT assay could be due to the
fact that these extracts were able to inhibit the cytopatic
effect without inhibiting the virus replication in Vero E6
cells. Among the six plant extracts tested, C. limon and
P. citrosum did not prevent CPE or cell death from the
effects of DENV-1. The normal polygonal-shaped cells
were not visible followed by widespread of cell death,
indicated by the amount of debris strewn across Figures
4E and 4F. Furthermore, cells treated with P. citrosum
showed granulation and cell densing (pyknosis).
A. paniculata, C. limon, C. citratus, M. charantia, O.
sanctum and P. citrosum have been traditionally known
to possess antiviral activity. Out of the six plants tested,
C. citratus, O. sanctum, P. citrosum and C. limon
showed no anti-dengue activity even though some of
their methanolic extracts exhibited high total flavonoids
content. One of the possible explanations to this non-
inhibitory effect could be that there lies a relationship
between the structure of the flavonoids and antiviral
activity as described by Sanchez et al. [12]. It was found
Figure 3 Various cytopathic effects observed in DENV-1-infected Vero E6 cells after 7 days post infection. (A) The monolayer sheet of
cells at 100× magnification appeared to be congested and haphazard. (B) A typical syncythial giant cell formation or syncytia resulting from the
fusion of a few cells infected with DENV-1 viewed at 200× magnification. The morphological changes appeared to be group of cells without a
clear white demarcation of cell membrane. The cells located at the perimeter of the syncytia were observed clearly. (C) Areas of cell death or
lysis are pointed out by the arrows. These small areas were clear of any cells and reflected the colour of the pink medium. (D) A higher
magnification image (400×) showing white dots called blebs.
Table 2 Antiviral assay based on cytopathic effects
denoted by degree of inhibition upon treating the
DENV1-infected Vero E6 cells with maximum non-toxic
dose of six medicinal plants.







+++ 75% inhibition, ++ 50% inhibition, + < 50% inhibition, - no inhibition
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in their comparative study that flavonoids with no pre-
nyl side-chain totally lacked anti-dengue activity. P.
citrosum and C. limon extracts showed obvious cell
death when treated with DENV-1 infected control cells.
A possible explanation to this result could be that the
compounds present in these plants could have affected
cell proliferation instead of virus replication [12], thus,
preventing the cell sheet from regrowing after DENV-1
infected cell death.
In this preliminary screening study for anti-dengue
agent, methanolic extract of A. paniculata and M. char-
antia was found to have high potential to be an anti-
dengue agent, particularly towards DENV-1 serotype. A.
paniculata extract showed a total of 75% of inhibition
while M. charantia showed approximately 50% of inhi-
bition on CPE upon infection with DENV-1. These find-
ings suggested that the anti-dengue activity might be
owing to the presence of flavonoid compounds or other
Figure 4 Morphological changes of DENV-1-infected Vero E6 cells treated with methanolic extracts of six medicinal plants at 7 days
post infection. All the cells were viewed under inverted microscope at 200× magnification. (A) A. paniculata with75% of inhibition. (B) M.
charantia with 50% of inhibition. (C) O. sanctum with less than 50% inhibition. (D) C. citratus with less than 50% inhibition (E) C. limon with no
inhibition. Only cell fragments and debris were seen (F) P. citrosum with no inhibition. Granulation and cell densing were observed. The CPE for
each treatment was compared with those of negative and positive controls shown in Figures 2 and 3, respectively.
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compounds such as terpenes and polyphenols that were
extractable by methanol. Various flavonoid compounds
have been documented to possess antiviral properties.
For instance, M. charantia that was reported to show
anti-HSV-1, polio type 1, parainfluenza and respiratory
syncytial virus activities [21] was found to contain flavo-
noids such as lutelin, kampherol and quercetin [19]. Fla-
vonoids are able to inhibit viruses by inhibiting different
pathways. Chang et al [31] disclosed that dehydroandro-
grapholide succinic acid monoester (DASM) could inter-
fere with cell fusion, thus preventing HIV from entering
the cell. Alternately, certain flavonoids with potent anti-
HIV effects are capable of inhibiting virus associated
reverse transcriptase and even cellular DNA or RNA
polymerase [32].
Even though flavonoid compounds have been the
main constituent of interest in search of anti-dengue
agent, the role of diterpenes such as andrographolide,
14-deoxyandrographolide and 14-deoxy-11,12-didehy-
droandrographolide present in methanolic extract of A.
paniculata [33] against DENV-1 should not be
neglected. Andrographolide, and 14-deoxy-11,12-didehy-
droandrographolide have been reported to exhibit anti-
HIV activity [34]. Similarly, methanolic extract of M.
charantia was found to contain terpenes, saponins and
steroids [35,36]. In a related study, the methanolic
extract of M. charantia was presumed to contain the
major compound such as unglycosides terpenes [37].
However, there is a lack of literature to support that
unglycoside terpenes cause any antiviral activity.
There are two probable pathways that could be the
mode of antiviral action: 1) interfere with viral adsorp-
tion, and 2) inhibit viral replication. Schitzler et al. [38]
noted that pre-treatment of the cells might give the cells
protective effects against viruses by preventing viral
adsorption. Furthermore, the dengue virus E protein is a
potential target of inhibition due to its principal role in
cell membrane adhesion [39]. As such, there is a possi-
bility that the extract supplied might have blocked the E
protein. Alternatively, the inhibitive event could have
also occurred during viral replication. One stage of inhi-
bition of viral replication by flavonoids was found using
flavonoid SP-303, which showed a mode of antiviral
action on DNA and RNA synthesis [32]. Another stage
of inhibition of viral replication might be by blocking
certain enzymes, such as an antiviral compound (NITD-
982) that inhibit an enzyme needed for pyrimidine bio-
synthesis [40]. Non-structural proteins are also potential
targets of inhibition. For example, a study on STAT2, a
component of type-1 interferon signalling pathway that
is targeted for degradation once nNS5 is bound to it.
The study showed that mouse STAT2 could restrict
early dengue virus replication in vivo [41].
Conclusions
Studies on Andrographis paniculata and Momordica
charantia that showed anti-dengue properties should be
further conducted extensively. Isolation, purification and
characterisation of the active compounds in order to
discover the potential anti-dengue compounds should
be carried out. Furthermore, investigations into the
mode of action of anti-dengue activities by the active
compounds can be done to provide more insight into
inhibition of dengue adsorption and replication.
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Table 3 The percentage of cell viability as measured by
MTT assay upon treating the DENV1-infected Vero E6
cells with maximum non-toxic dose of six medicinal
plants.
Treatments Cell viability (%)
Control (Untreated cells) 100.00 ± 10.50*
Positive control (Cells infected with DENV-1) 44.60 ± 4.42
Andrographis paniculata 113.00 ± 4.65*
Momordica charantia 98.00 ± 8.69*
Cymbopogn citrates 32.00 ± 6.93
Ocimum sanctum 48.00 ± 7.16
Citrus limon 52.00 ± 7.54
Pelargonium citrosum 41.40 ± 2.75
The data shown are mean ± S.D. ‘*’ denotes significant difference at P < 0.05,
compared to the positive control using unpaired t-test, performed by
GraphPad Instat version 3.0.
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